CT引导下肺结节活检-冷冻消融中先行消融与先行活检策略的比较:一项回顾性队列研究
该回顾性队列纳入60例(60个肺结节)行CT引导下活检-冷冻消融的患者,比较先行消融组(28例)与先行活检组(32例)的技术成功率、活检阳性率、1年无病生存率及并发症。先行消融组总并发症发生率(53.6% vs 78.1%,P=0.04)及术中出血率(10.7% vs 40.6%,P=0.03)均低于先行活检组,活检阳性率两组无显著差异(85.7% vs 78.1%,P=0.423)。
要点
- 先行消融组总并发症发生率53.6%,低于先行活检组的78.1%(P=0.04)。
- 先行消融组术中出血率10.7%,低于先行活检组的40.6%(P=0.03)。
- 血管旁结节位置(OR 4.20,95%CI 1.55-11.40,P=0.005)与先行活检策略(OR 3.70,95%CI 1.25-11.10,P=0.018)与术中出血独立相关。
核心结论
- 与先行活检策略相比,先行消融策略在CT引导下肺结节活检-冷冻消融中活检阳性率相当,但出血风险更低。
研究设计与样本
- 回顾性队列研究,纳入2023年2月至2023年10月作者中心60例患者(60个肺结节),先行消融组28例、先行活检组32例,均行CT引导下活检-冷冻消融。
诊断标准与关键数值
- 技术成功率100%,中位随访时间13个月,1年无病生存率100%;活检阳性率先行活检组78.1%(25/32) vs 先行消融组85.7%(24/28),P=0.423,两组无显著差异。
临床应用与阅片要点
- 术中出血独立相关因素包括血管旁结节位置(OR 4.20,95%CI 1.55-11.40,P=0.005)及先行活检策略(OR 3.70,95%CI 1.25-11.10,P=0.018)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: The aim of this study was to investigate the safety and diagnostic performance of ablation-first versus biopsy-first approach for computed tomography (CT)-guided biopsy-cryoablation of pulmonary nodules.
MATERIALS AND METHODS: This retrospective analysis included 60 patients (60 pulmonary nodules) undergoing CT-guided biopsy-cryoablation between February 2023 and October 2023 at authors' centre: 28 in the ablation-first cohort and 32 in the biopsy-first cohort. The two groups were compared in technical success rate, positive biopsy rate, 1-year disease-free survival (DFS) rate, and procedure-related complications. Multivariate logistic regression was conducted to identify variables associated with haemorrhage; results are shown as odds ratio (OR) and 95% confidence interval (CI).
RESULTS: The mean size of pulmonary nodules was 1.6 ± 0.5 cm. The technical success rate was 100%, the median follow-up time was 13 months, and the 1-year DFS rate was 100%. The positive biopsy rate was 78.1% (25/32) in the biopsy-first cohort and 85.7% (24/28) in the ablation-first cohort (P=0.423). The ablation-first cohort had a lower rate of total procedure-related complications (53.6% vs 78.1% in the biopsy-first cohort, P=0.04) as well as a lower rate of intraoperative bleeding (10.7% vs 40.6%, P=0.03). In the multivariable regression analysis, intraoperative haemorrhage was independently associated with perivascular nodule location (OR: 4.20, 95% CI: 1.55-11.40, P=0.005) and the biopsy-first approach (OR: 3.70, 95% CI: 1.25-11.10, P=0.018).
CONCLUSION: In comparison to biopsy-first approach, ablation-first approach was associated with comparable positive biopsy rate but lower haemorrhage risk in patients undergoing CT-guided biopsy-cryoablation of pulmonary nodules.
引用
- Lai L, Xu F, Tu J, et al. Ablation-first versus biopsy-first strategy in computed tomography (CT)-guided biopsy-cryoablation for pulmonary nodules: a retrospective cohort study. Clin Radiol. 2025. PMID: 42048903. doi:10.1016/j.crad.2025.107223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。